REQUEST A DEMO
Total
USD $0.00
Search more companies

Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Edding Genor Group Holdings Limited Profile Updated: May 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) is a company in China, with a head office in Shanghai. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 10, 2017. Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) currently employs 1,545 (2025) people. There was a net sales revenue drop of 2.3% reported in Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司)’s latest financial highlights for 2025. Over the same period, its total assets grew by 21.37%. The enterprise’s net profit margin increased by 0.81% in 2025.

Headquarters
Building 3, 1690 Zhangheng Road, Pudong New District
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.

Website: http://www.genorbio.com

Basic Information
Total Employees:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Outstanding Shares:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Registered Capital:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Financial Auditors:
Purchase the Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report to view the information.
Incorporation Date:
April 10, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
24.26%
Purchase this report to view the information.
8.52%
Purchase this report to view the information.
7.22%
Purchase this report to view the information.
5.6%
Purchase this report to view the information.
2.59%
Subsidiaries
Genor Biopharma (Hk) Limited (Hong Kong SAR, China)
100%
Genor Biopharma (Usa), Inc (United States)
100%
Ab Therapeutics Inc. (Abt) (United States)
80%
Company Performance
Financial values in the chart are available after Edding Genor Group Holdings Limited (亿腾嘉和医药集团有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-2.3%
Total Operating Revenue
-2.36%
Operating Profit
-15.42%
EBITDA
-0.24%
Net Profit/Loss for the Period
2.93%
Total Assets
21.37%
Total Equity
59.82%
Operating Profit Margin
-3.81%
Net Profit Margin
0.81%
Return on Equity (ROE)
-5.73%
Debt / Equity
-45.8%
Quick Ratio
0.41%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?